Company details
StratifAI
Berlin AI precision-oncology company developing cancer biomarkers.
Stability signals
- CEO
- Omar El Nahhas
- Founders
- Omar El Nahhas, Jakob Nikolas Kather, Daniel Truhn, Firas Khader
- Total raised
- €14M
- Recent rounds
- September 2025 · €13M · Series A
- September 2024 · €2M · Pre-seed
- Founders' prior
companies - TU Dresden / Else Kroener Fresenius Center for Digital Health (EKFZ) - Omar El Nahhas (PhD) and Jakob Nikolas Kather (professor, computational oncology), RWTH Aachen University / University Hospital Aachen - Daniel Truhn and Firas Khader
Verified 2026-06-10
Open roles
No active roles right now. Check back after the next daily poll.